Supplementation of iron in pulmonary hypertension: Rationale and design of a phase II clinical trial in idiopathic pulmonary arterial hypertension

Our aim is to assess the safety and potential clinical benefit of intravenous iron (Ferinject) infusion in iron deficient patients with idiopathic pulmonary arterial hypertension (IPAH). Iron deficiency in the absence of anemia (1) is common in patients with IPAH; (2) is associated with inappropriat...

Descripción completa

Detalles Bibliográficos
Autores principales: Howard, Luke S.G.E., Watson, Geoffrey M.J., Wharton, John, Rhodes, Christopher J., Chan, Kakit, Khengar, Rajeshree, Robbins, Peter A., Kiely, David G., Condliffe, Robin, Elliott, Charlie A., Pepke-Zaba, Joanna, Sheares, Karen, Morrell, Nicholas W., Davies, Rachel, Ashby, Deborah, Gibbs, J. Simon R., Wilkins, Martin R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641712/
https://www.ncbi.nlm.nih.gov/pubmed/23662181
http://dx.doi.org/10.4103/2045-8932.109923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641712/
https://www.ncbi.nlm.nih.gov/pubmed/23662181
http://dx.doi.org/10.4103/2045-8932.109923

Ejemplares similares